IBM's stock fell sharply after the company unexpectedly released its second-quarter results a week early, revealing both profit and revenue below analyst expectations. The disappointing performance was linked to the delayed launch of the z17 mainframe program, which was expected to conclude in Q2. This miss marks one of IBM's worst trading days in nearly 40 years, signaling potential challenges ahead for the tech giant. Investors will be closely watching how IBM addresses these setbacks in its upcoming full earnings report.
IBM reported it has struggled to keep up with a shift in corporate spending from software to data-center infrastructure, forecasting second-quarter earnings below analyst estimates. The company cited a significant reprioritization of capital expendit...
IBM shares plunged more than 26% in five days following a downgrade to 'Sell' by HSBC analyst Stephen Bersey, who cited high valuation and slower earnings growth compared to peers. The stock also fell sharply after IBM reported weaker-than-expected Q...
IBM's shares fell about 25% after its preliminary Q2 2026 results missed Wall Street expectations, reporting earnings of $2.93 per share on $17.2 billion revenue versus expected $3.01 per share on $17.86 billion. The company cited an unexpected shift...
IBM shares dropped over 23% following its Q2 earnings report, which showed profits and revenue below analyst expectations. CEO Arvind Krishna highlighted that the company's mainframe business, particularly the Z series with AI capabilities, underperf...
IBM reported Q2 adjusted earnings of $2.93 per share and revenue of $17.2 billion, missing analyst forecasts of $3.01 per share and $17.86 billion revenue. CEO Arvind Krishna cited a shift in client spending from software to hardware like memory chip...
